TWO scientists have challenged one of the world’s most successful publishing companies by urging colleagues to boycott its prestige journals.

They claim that Cell Press, part of the Anglo-Dutch Reed Elsevier group, is charging excessive subscription fees and profiteering at the expense of the academic community.

Peter Walter and Keith Yamamoto, from the University of California at San Francisco, are urging fellow scientists not to submit articles to Cell or to five sister publications until the publishers change their policy. “We can all think of better ways to spend our time than providing free services to support a publisher that values profit above its academic mission,” Dr Walter and Dr Yamamoto said.

Behind the dispute lies a growing reluctance by universities to pay the large fees charged by publishers for electronic access to their journals, and the growth of a new type of scholarly publishing online, where the costs are paid by the authors and not the readers.

If this new model succeeds, it will make all scientific information available free on the internet. But the conventional publishers behind the huge prestige of journals such as Cell, Nature, Science, Lancet and The New England Journal of Medicine, are hoping that “open access” will come to nothing. Some have moved to weaken its appeal by making their own journal content freely available six months after publication.

The dispute in the United States centres on efforts by the University of California at San Francisco to make Elsevier journals available to all its academics online. In 2002, the university paid Elsevier $8 million (£4.8 million) for this privilege, but the six Cell titles were not included in the package.

This year, Dr Walter and Dr Yamamoto said that Elsevier wanted substantial increases in the fee, plus an additional $90,000 for Cell Press titles. Lynne Herndon, President of Cell Press, said its pricing was fair and reasonable. The library has refused to pay.

A new report by the French bank, BNP Paribas, has estimated that journals in science, technology and medicine generate $8 billion a year. Elsevier accounted for $1.3 billion of that. A Wellcome Trust report said that year-on-year subscription increases have averaged more than 10 per cent.

The Open Access pioneers believe that the internet is the answer. Two groups have established online journals: Biomed Central in Britain, and the Public Library of Science in the US. Biomed Central now has 90 journals, with its top title the Journal of Biology. It remains to be seen whether scientists and doctors are willing to give up the cachet of publication in a top journal.

The company says that once online access to journals is in place, individuals can cancel subscriptions, presenting “the opportunity for savings”.

Explore World News

• World Agenda

• Iraq News

• US & Americas News

• Europe News

• Middle East News

• Asia News

• Africa News

• Ireland News

Times Recommends

• Fish and chip shops ‘selling cobbler as cod’
• T in the Park festival at Kinross
• Body Watch